Personas / Equipo Humano

Janet Hoenicka

Buscador de publicaciones

Publicaciones

  • Martínez-Gras I, Hoenicka J, Ponce G, Rodríguez-Jiménez R, Jiménez-Arriero MA, Pérez-Hernandez E, Ampuero I, Ramos-Atance JA, Palomo T and Rubio G.

    (AAT)n repeat in the cannabinoid receptor gene, CNR1:: association with schizophrenia in a Spanish population

    European archives of psychiatry and clinical neuroscience . 256(7): 437-441. Nº de citas: 74

    [doi:10.1007/s00406-006-0665-3]

  • Hoenicka J.

    Genes in Alzheimer's disease

    REVISTA DE NEUROLOGIA . 42(5): 302-305. Nº de citas: 27

    [doi:10.33588/rn.4205.2005486]

  • Jiménez-Arriero, MA, Ponce, G, Rodríguez-Jiménez, R, Aragués, M, Galvan, A, Rubio, G, Hoenicka J and Palomo, T.

    TaqI-A polymorphism linked to the DRD2 gene and P300 in alcoholic patients

    EUROPEAN JOURNAL OF PSYCHIATRY . 20(1): 45-53. Nº de citas: 10

  • Rodríguez-Jiménez R, Avila C, Ponce G, Ibáñez MI, Rubio G, Jiménez-Arriero MA, Ampuero I, Ramos JA, Hoenicka J and Palomo T.

    The Taq IA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients

    EUROPEAN PSYCHIATRY . 21(1): 66-69. Nº de citas: 45

    [doi:10.1016/j.eurpsy.2005.05.010]

  • Rodriguez-Jimenez R, Hoenicka J, Jimenez-Arriero MA, Ponce G, Bagney A, Aragues M and Palomo T.

    Performance in the Wisconsin card sorting test and the C957T polymorphism of the DRD2 gene in healthy volunteers

    Neuropsychobiology . 54(3): 166-170. Nº de citas: 65

    [doi:10.1159/000098652]

  • Ros R, Thobois S, Streichenberger N, Kopp N, Sánchez MP, Pérez M, Hoenicka J, Avila J, Honnorat J and de Yébenes JG.

    A new mutation of the t gene, G303V, in early-onset familial progressive supranuclear palsy

    Archives of Neurology . 62(9): 1444-1450. Nº de citas: 76

    [doi:10.1001/archneur.62.9.1444]

  • Rubio G, Ponce G, Rodriguez-Jiménez R, Jiménez-Arriero MA, Hoenicka J and Palomo T.

    Clinical predictors of response to naltrexone in alcoholic patients:: Who benefits most from treatment with naltrexone?

    ALCOHOL AND ALCOHOLISM . 40(3): 227-233. Nº de citas: 80

    [doi:10.1093/alcalc/agh151]

  • Ros R, Gómez Garre P, Hirano M, Tai YF, Ampuero I, Vidal L, Rojo A, Fontan A, Vazquez A, Fanjul S, Hernandez J, Cantarero S, Hoenicka J, Jones A, Ahsan RL, Pavese N, Piccini P, Brooks DJ, Perez-Tur J, Nyggard T and de Yébenes JG.

    Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1

    ANNALS OF NEUROLOGY . 57(5): 634-641. Nº de citas: 37

    [doi:10.1002/ana.20449]

  • Barrero FJ, Ampuero I, Morales B, Vives F, de Dios Luna Del Castillo J, Hoenicka J and García Yébenes J.

    Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)

    PHARMACOGENOMICS JOURNAL . 5(2): 135-141. Nº de citas: 108

    [doi:10.1038/sj.tpj.6500301]

  • Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG and de Yebenes JG.

    The new mutation, E46K, of a-synuclein causes Parkinson and Lewy body dementia

    ANNALS OF NEUROLOGY . 55(2): 164-173. Nº de citas: 2540

    [doi:10.1002/ana.10795]